AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Article Link
Collect
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Knowledge domain and emerging trends in brachytherapy: A scientometric analysis

Arash Ghazbani1Mohammad Abdolahi2Mohammad Javad Mansourzadeh3Reza BasirianJahromi4Sina Behzadipour1Anali Mohseni Azad5Bardia Talebzadeh6Abdolrasoul Khosravi4Ali Hamidi4 ( )
Student Research Committee, Bushehr University of Medical Sciences, Bushehr, Iran
Department of Radiology, Faculty of Paramedicine, Bushehr University of Medical Sciences, Bushehr, Iran
School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
Department of Medical Library and Information Sciences, Faculty of Paramedicine, Bushehr University of Medical Sciences, Bushehr, Iran
Department of Surgery, Faculty of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran
Faculty of Pharmacy, Semmelweis University, Budapest, Hungary
Show Author Information

Abstract

Objective

Assessing the current scientific situation helps to recognize the gaps and strengths of brachytherapy research projects. This research project was conducted to assess the knowledge domain and emerging trends in brachytherapy through a scientometric perspective.

Methods

For the present research, the Web of Science database was considered as the data source. Integrated data was transferred to Bibliometrix R Package V3.1. In this study, the scientometric approach was performed by CiteSpace 5.8.R3 to draw the trends and signify issues in the research area. Eventually, scientometric indicators were evaluated at the level of authors, documents, journals, organizations, and countries.

Results

A total of 31,362 documents from 64,740 Independent researchers were retrieved. The United States, Germany, and Canada were the most active countries in brachytherapy-related research projects. In the present study, Luc Beaulieu, Christine Kirisits, and Ronald Nath were identified as the most influential authors. Eventually, keywords clusters were constructed by using the method of co-citation analysis. In this case, the main clusters were cervical cancer and prostate cancer.

Conclusion

Assessing the scientific trends in brachytherapy indicated that new insights have been gained into this cancer treatment technique. In this case, development of computer applications and artificial intelligence alongside deep learning utilization provides new horizons for oncology and radiotherapy researchers.

References

1

Atun R, Jaffray DA, Barton MB, et al. Expanding global access to radiotherapy. Lancet Oncol. 2015; 16(10): 1153-1186.

2

Alterio D, Marvaso G, Ferrari A, Volpe S, Orecchia R, Jereczek-Fossa BA. Modern radiotherapy for head and neck cancer. Semin Oncol. 2019; 46(3): 233-245.

3
De Ruysscher D, Niedermann G, Burnet NG, Siva S, Lee AWM, Hegi-Johnson F. Nat Rev Dis Primers. 2019; 5(1): 1-20.
4

Barton MB, Frommer M, Shafiq J. Role of radiotherapy in cancer control in low-income and middle-income countries [published correction appears in Lancet Oncol. 2006 Oct; 7(10): 797]. Lancet Oncol. 2006; 7(7): 584-595.

5

Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012; 9(3): 193-199.

6

Mazzola R, Corradini S, Eidemüeller M, et al. Modern radiotherapy in cancer treatment during pregnancy. Crit Rev Oncol Hematol. 2019; 136: 13-19.

7

Kageyama SI, Du J, Kaneko S, et al. Identification of the mutation signature of the cancer genome caused by irradiation. Radiother Oncol. 2021; 155: 10-16.

8

Dilalla V, Chaput G, Williams T, Sultanem K. Radiotherapy side effects: integrating a survivorship clinical lens to better serve patients. Curr Oncol. 2020; 27(2): 107-112.

9

Veness MJ, Delishaj D, Barnes EA, Bezugly A, Rembielak A. Current role of radiotherapy in non-melanoma skin cancer. Clin Oncol (R Coll Radiol). 2019; 31(11): 749-758.

10

Tanderup K, Ménard C, Polgar C, Lindegaard JC, Kirisits C, Pötter R. Advancements in brachytherapy. Adv Drug Deliv Rev. 2017; 109: 15-25.

11

Chargari C, Deutsch E, Blanchard P, et al. Brachytherapy: an overview for clinicians. CA Cancer J Clin. 2019; 69(5): 386-401.

12

Derks K, Steenhuijsen JLG, van den Berg HA, et al. Impact of brachytherapy technique (2D versus 3D) on outcome following radiotherapy of cervical cancer. J Contemp Brachytherapy. 2018; 10(1): 17-25.

13

Zaorsky NG, Davis BJ, Nguyen PL, et al. The evolution of brachytherapy for prostate cancer. Nat Rev Urol. 2017; 14(7): 415-439.

14

Deng X, Wu H, Gao F, et al. Brachytherapy in the treatment of breast cancer. Int J Clin Oncol. 2017; 22(4): 641-650.

15

Rodin J, Bar-Ad V, Cognetti D, et al. A systematic review of treating recurrent head and neck cancer: a reintroduction of brachytherapy with or without surgery. J Contemp Brachytherapy. 2018; 10(5): 454-462.

16

Sh Djalalinia, Owlia P, Forouzan AS, et al. Health research evaluation and its role on knowledge production. Iran J Public Health. 2012; 41(2): 39-46.

17

Wallin JA. Bibliometric methods: pitfalls and possibilities. Basic Clin Pharmacol Toxicol. 2005; 97(5): 261-275.

18

Tang X, Li F, Yang Y, Zhao H, Mu X, Mao Z. The 100 most cited articles in prostate cancer brachytherapy: systematic review and bibliometric analysis. J Contemp Brachytherapy. 2020; 12(3): 283-289.

19

Donath E, Alcaidinho A, Delouya G, Taussky D. The one hundred most cited publications in prostate brachytherapy. Brachytherapy. 2021; 20(3): 611-623.

20

Li K, Rollins J, Yan E. Web of Science use in published research and review papers 1997–2017: a selective, dynamic, cross-domain, content-based analysis. Scientometrics. 2018; 115(1): 1-20.

21

Mendez LC, Weiss Y, D'Souza D, Ravi A, Barbera L, Leung E. Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: a systematic review of technique, local control and toxicities. Radiother Oncol. 2017; 123(2): 312-318.

22

Sánchez-Gómez LM, Polo-deSantos M, Rodríguez-Melcón JI, Angulo JC, Luengo-Matos S. High-dose rate brachytherapy as monotherapy in prostate cancer: a systematic review of its safety and efficacy. Actas Urol Esp. 2017; 41(2): 71-81.

23

Fuccio L, Mandolesi D, Farioli A, et al. Brachytherapy for the palliation of dysphagia owing to esophageal cancer: a systematic review and meta-analysis of prospective studies. Radiother Oncol. 2017; 122(3): 332-339.

24

Aria M, Cuccurullo C. bibliometrix: an R-tool for comprehensive science mapping analysis. J Informetr. 2017; 11(4): 959-975.

25

Chen C. CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci. 2006; 57(3): 359-377.

26

Chen C, Ibekwe-SanJuan F, Hou J. The structure and dynamics of cocitation clusters: a multiple-perspective cocitation analysis. J Am Soc Inf Sci. 2010; 61(7): 1386-1409.

27

Chen C. The citespace manual. Colg C Inf. 2014; 1: 1-84.

28

Chen C, Chen Y, Horowitz M, et al. Towards an explanatory and computational theory of scientific discovery. J Inf. 2009; 3(3): 191-209.

29

Boyack KW, Klavans R. Co-citation analysis, bibliographic coupling, and direct citation: which citation approach represents the research front most accurately? J Am Soc Inf Sci. 2010; 61(12): 2389-2404.

30

Aggarwal A, Lewison G, Rodin D, Zietman A, Sullivan R, Lievens Y. Radiation therapy research: a global analysis 2001–2015. Int J Radiat Oncol Biol Phys. 2018; 101(4): 767-778.

31

Sullivan R, Purushotham AD. Avoiding the zero sum game in global cancer policy: beyond 2011 UN high level summit. Eur J Cancer. 2011; 47(16): 2375-2380.

32

Aggarwal A, Lewison G, Idir S, et al. The state of lung cancer research: a global analysis. J Thorac Oncol. 2016; 11(7): 1040-1050.

33

Dimopoulos JC, De Vos V, Berger D, et al. Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations. Radiother Oncol. 2009; 91(2): 166-172.

34

Lang S, Nulens A, Briot E, et al. Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations. Radiother Oncol. 2006; 78(2): 185-193.

35

Pötter R, Dimopoulos J, Kirisits C, et al. Recommendations for image-based intracavitary brachytherapy of cervix cancer: the GYN GEC ESTRO Working Group point of view: in regard to Nag et al. (Int J Radiat Oncol Biol Phys 2004;60: 1160-1172). Int J Radiat Oncol Biol Phys. 2005; 62(1): 293-296.

36

Pötter R, Tanderup K, Kirisits C, et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018; 9: 48-60.

37

Schmid MP, Fokdal L, Westerveld H, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group -ACROP: target concept for image guided adaptive brachytherapy in primary vaginal cancer. Radiother Oncol. 2020; 145: 36-44.

38

Hellebust TP, Kirisits C, Berger D, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol. 2010; 96(2): 153-160.

39

Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006; 78(1): 67-77.

40

Haie-Meder C, Pötter R, Van Limbergen E, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005; 74(3): 235-245.

41

Siebert FA, Kirisits C, Hellebust TP, et al. GEC-ESTRO/ACROP recommendations for quality assurance of ultrasound imaging in brachytherapy. Radiother Oncol. 2020; 148: 51-56.

42

Kovács G, Pötter R, Loch T, et al. GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol. 2005; 74(2): 137-148.

43
brachytherapist AronowitzJNRobertAbbe: earlyAmerican. Brachytherapy. 2012; 11(6): 421-428.
44

Danlos H, Bloch P. Note sur le traitement du lupus érythémateux par des applications du radium. Ann Dermatol Syphilog. 1901; 2: 986-988.

45
Kuske RR Jr. Breast brachytherapy Hematol Oncol Clin North Am. 1999; 13(3): 543.
46

Garzotto M, Fair WR. Historical perspective on prostate brachytherapy. J Endourol. 2000; 14(4): 315-318.

47

Denning C. Carcinoma of the prostate seminal vesicles treated with radium. Surg Gynecol Obstet. 1922; 34: 99-118.

48

Zelefsky MJ. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer. J Urol. 1997; 158(1): 23-30.

49

Blasko JC, Ragde H, Luse RW, Sylvester JE, Cavanagh W, Grimm PD. Should brachytherapy be considered a therapeutic option in localized prostate cancer? Urol Clin North Am. 1996; 23(4): 633-650.

50

Heysek RV. Modern brachytherapy for treatment of prostate cancer. Cancer Control. 2007; 14(3): 238-243.

51

Holm HH, Juul N, Pedersen JF, Hansen H, Strøyer I. Transperineal 125iodine seed implantation in prostatic cancer guided by transrectal ultrasonography. 1983. J Urol. 2002; 167(2 Pt 2): 985-989.

52

Zaorsky NG, Harrison AS, Trabulsi EJ, et al. Evolution of advanced technologies in prostate cancer radiotherapy. Nat Rev Urol. 2013; 10(10): 565-579.

53

Mate TP, Gottesman JE, Hatton J, Gribble M, Van Hollebeke L. High dose-rate afterloading 192Iridium prostate brachytherapy: feasibility report. Int J Radiat Oncol Biol Phys. 1998; 41(3): 525-533.

54

Marcus DM, Jani AB, Godette K, Rossi PJ. A review of low-dose-rate prostate brachytherapy–techniques and outcomes. J Natl Med Assoc. 2010; 102(6): 500-510.

55
Janeway HH. Radium Therapy in Cancer at the Memorial Hospital. PB Hoeber; 1917.
56

Shank B. Breast preservation and brachytherapy. Endocuriether Hyperther Oncol. 1986; 2: 17-24.

57

Keynes G. The treatment of primary carcinoma of the breast with radium. Acta Radiol. 1929; 10: 393-402.

58

Polgár C, Strnad V, Major T. Brachytherapy for partial breast irradiation: the European experience. Semin Radiat Oncol. 2005; 15(2): 116-122.

59

Polgár C, Major T. Current status and perspectives of brachytherapy for breast cancer. Int J Clin Oncol. 2009; 14(1): 7-24.

60

Bensaleh S, Bezak E, Borg M. Review of MammoSite brachytherapy: advantages, disadvantages and clinical outcomes. Acta Oncol. 2009; 48(4): 487-494.

61

Sarin R, Chopra S. Accelerated partial breast irradiation using multicatheter brachytherapy. Nat Clin Pract Oncol. 2007; 4(7): 382-383.

62

Williamson JF. Brachytherapy technology and physics practice since 1950: a half-century of progress. Phys Med Biol. 2006; 51(13): R303-R325.

63

Rivard MJ, Venselaar JL, Beaulieu L. The evolution of brachytherapy treatment planning. Med Phys. 2009; 36(6): 2136-2153.

64

Thomadsen BR, Williamson JF, Rivard MJ, Meigooni AS. Anniversary paper: past and current issues, and trends in brachytherapy physics. Med Phys. 2008; 35(10): 4708-4723.

65

Pötter R, Haie-Meder C, Van Limbergen E, et al. Recommendations from gynecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose-volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol. 2006; 78(1): 67-77.

66

Warszawski N, Bleher M, Bratengeier K, Bohndorf W. The use of isodose curves on radiographs and on CT scans in interstitial brachytherapy. Clin Oncol (R Coll Radiol). 1992; 4(4): 228-231.

67

Hardy TL, Brynildson LR, Gray JG, Spurlock D. Three-dimensional imaging for brachytherapy planning. Stereotact Funct Neurosurg. 1992; 59(1-4): 179-181.

68

Warszawski N, Pfreundner L, Bratengeier K, Bohndorf W, Feustel H. Combined isodose curves of high-dose rate interstitial brachytherapy with external-beam radiation therapy in pancreatic carcinoma. Strahlenther Onkol. 1992; 168(9): 552-557.

69

Viswanathan AN, Erickson BA, Ibbott GS, Small W Jr, Eifel PJ, The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. Brachytherapy. 2017; 16(1): 68-74.

70

Viswanathan AN, Erickson BA. Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society. Int J Radiat Oncol Biol Phys. 2010; 76(1): 104-109.

71

Banerjee R, Kamrava M. Brachytherapy in the treatment of cervical cancer: a review. Int J Womens Health. 2014; 6: 555-564.

72

Haie-Meder C, Mazeron R, Verezesan O, et al. Apport des techniques de curiethérapie optimisée grâce à l'imagerie tridimensionnelle dans la prise en charge des patientes atteintes d'un cancer du col utérin [Three-dimensional brachytherapy optimization techniques in the treatment of patients with cervix cancer]. Cancer Radiother. 2009; 13(6-7): 520-524.

Precision Radiation Oncology
Pages 243-256
Cite this article:
Ghazbani A, Abdolahi M, Mansourzadeh MJ, et al. Knowledge domain and emerging trends in brachytherapy: A scientometric analysis. Precision Radiation Oncology, 2022, 6(3): 243-256. https://doi.org/10.1002/pro6.1171

352

Views

1

Crossref

1

Scopus

Altmetrics

Received: 08 July 2022
Revised: 09 August 2022
Accepted: 16 August 2022
Published: 14 September 2022
© 2022 The Authors. Precision Radiation Oncology published by John Wiley & Sons Australia, Ltd on behalf of Shandong Cancer Hospital & Institute.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Return